Myxoid Solitary Fibrous Tumor of the Vulva: A Diagnostic Pitfall.

Int J Gynecol PatholFeb 18, 2026 (epub)

Ahmet Erbağci, Abdullah Aydin, Filiz Özen et al.

✦ AI-curated · Sources linked

Case in brief

A 35-year-old woman presented with a slowly enlarging vulvar mass that imaging suggested was a benign cystic lesion. Histology instead showed a predominantly myxoid spindle-cell tumor, with staghorn-shaped vessels at the periphery. Diffuse nuclear STAT6 and CD34 positivity on immunohistochemistry, together with molecular confirmation of a NAB2:::STAT6 fusion, established the diagnosis of myxoid solitary fibrous tumor. The report does not describe treatment or clinical outcome.

What made this case unusual

Extensive myxoid change gave this vulvar solitary fibrous tumor atypical imaging and histologic features, creating a diagnostic pitfall: it was interpreted radiologically as a benign cystic lesion.

Diagnostic / clinical pearl

In a myxoid vulvar spindle-cell tumor, morphology and imaging may be misleading; diffuse nuclear STAT6 and CD34 staining, with molecular confirmation of NAB2:::STAT6 fusion, supported the diagnosis.

Source

Published in Int J Gynecol Pathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pathology (Anatomic & Clinical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.